CNP
CNP (2',3'-cyclic nucleotide 3' phosphodiesterase, also known as CN37) is a member of the CNPase family within the 2H phosphoesterase superfamily. It is predicted to hydrolyse 2',3'-cyclic nucleotides and has also been described as an antiviral factor that restricts HIV-1 assembly. Browse Assay Genie's current range of CNP research reagents below, or read on for the biology behind the target.
CNP is an enzyme of the CNPase family, which belongs to the 2H phosphoesterase superfamily. Its name describes its predicted catalytic activity, 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity (EC 3.1.4.37). In addition to this enzymatic role, UniProt annotates CNP as an antiviral factor: it suppresses the assembly of HIV-1 virions through direct interaction with the viral GAG protein.
UniProt records the CNP protein in the melanosome, the mitochondrion and the cell membrane, while NCBI Gene summarises its location as cytoplasm and microtubule. The CNP gene is also reported to be involved in substantia nigra development. Mouse and rat both carry an orthologous Cnp gene, so rodent models are commonly considered for comparative work on this protein. The protein is also known by the alias CN37.
CNP has been implicated in several human conditions. NCBI Gene lists hypomyelinating leukodystrophy 20, multiple sclerosis and schizophrenia as diseases with which it is associated. It is also described as a biomarker of alcoholic liver cirrhosis, multiple sclerosis and restless legs syndrome. Researchers studying CNP therefore work across enzymology, virology and neurological disease, and a CNP antibody or CNP ELISA kit is often used to examine its abundance and localisation in these settings.
CNP is implicated in hypomyelinating leukodystrophy 20, multiple sclerosis and schizophrenia, making it a focus for studies of neurological disorders.
CNP suppresses HIV-1 virion assembly by interacting directly with GAG, offering a route to examine host restriction of retroviruses.
CNP is described as a biomarker of alcoholic liver cirrhosis, multiple sclerosis and restless legs syndrome.
CNP is involved in substantia nigra development, so it is relevant to studies of how this brain region forms.
CNP is predicted to have 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity. UniProt also annotates it as an antiviral factor that suppresses HIV-1 virion assembly through direct interaction with GAG. NCBI Gene adds that it is involved in substantia nigra development.
The HGNC-approved name is 2',3'-cyclic nucleotide 3' phosphodiesterase, and CN37 is a listed alias. UniProt uses the name 2',3'-cyclic-nucleotide 3'-phosphodiesterase. The enzyme is classified as EC 3.1.4.37 and sits in the CNPase family.
Mouse and rat each have an orthologous Cnp gene. In humans, CNP is implicated in hypomyelinating leukodystrophy 20, multiple sclerosis and schizophrenia. Check the datasheet of any product for its validated reactivity.
Other proteins with products at Assay Genie that may be of interest alongside CNP.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P09543; product specifications from Assay Genie datasheets.